Healthcare -
Biotechnology - NASDAQ - US
$ 118.0
0.803 %
$ 11.3 B
Market Cap
76.62
P/E
SRPT - COST OF REVENUE
Cost of Revenue SRPT - Sarepta Therapeutics, Inc.
150 M
LAST VALUE
24.46%
2 YEAR CAGR
34.47%
5 YEAR CAGR
5.23%
10 YEAR CAGR